Difficulty: Medium
Average Score: 71%
Practice
A client with chronic myeloid leukemia is receiving hydroxyurea. Which of the following findings should the nurse monitor?
Correct answer
C
Rationale
In this scenario, the correct answer is C) Neutropenia. When a client with chronic myeloid leukemia is receiving hydroxyurea, the nurse should monitor for neutropenia due to the drug's myelosuppressive effects. Hydroxyurea works by inhibiting DNA synthesis, which can lead to a decrease in neutrophil production and an increased risk of infection.
Option A) Hyperkalemia is incorrect because hydroxyurea does not typically cause hyperkalemia. Option B) Hypertension is also incorrect as it is not a common side effect of hydroxyurea. Option D) Tinnitus is not associated with hydroxyurea use and is an unrelated finding.
Educationally, understanding the side effects of medications is crucial in providing safe and effective care to patients. By monitoring for potential adverse effects like neutropenia in this case, nurses can intervene early to prevent complications and ensure optimal patient outcomes. It is essential to have a strong pharmacological knowledge base to make informed clinical decisions and provide quality care to patients receiving various medications.
Option A) Hyperkalemia is incorrect because hydroxyurea does not typically cause hyperkalemia. Option B) Hypertension is also incorrect as it is not a common side effect of hydroxyurea. Option D) Tinnitus is not associated with hydroxyurea use and is an unrelated finding.
Educationally, understanding the side effects of medications is crucial in providing safe and effective care to patients. By monitoring for potential adverse effects like neutropenia in this case, nurses can intervene early to prevent complications and ensure optimal patient outcomes. It is essential to have a strong pharmacological knowledge base to make informed clinical decisions and provide quality care to patients receiving various medications.